Pharmalive - The Pulse of the Pharmaceutical Industry
Search Criteria: Search In:  
Conferences


R&D Directions Insider

Archive for June, 2010

Recruitment reigns at DIA

Friday, June 18th, 2010

Patient recruitment and retention was a major theme at this week’s 46th DIA Annual Meeting in Washington, both in the educational sessions and on the show floor. By my count, the conference featured at least 11 panels exploring the topic, ranging in focus from who should be accountable for patient ...

Posted in CRO, Uncategorized, clinical trials | 1 Comment »

Wave of momentum for cancer immunotherapies

Friday, June 4th, 2010

Since the landmark approval of Provenge in late April for prostate cancer, much has been made of the significant buzz created for similar cancer immunotherapies (see stories here and here) that stimulate a patient’s immune system to recognize, attack, and kill tumor cells. Clinical data for a new wave of ...

Posted in antibodies, cancer, clinical trials | No Comments »

Long path for Prolia

Wednesday, June 2nd, 2010

Amgen’s anticipated bone-strengthening drug, also known as denosumab, has notched approvals in Europe and the United States in the last five days, the latter almost two months ahead of schedule. A whirlwind week to say the least for Amgen, a company whose fate, fair or not, has been pegged largely on ...

Posted in Uncategorized | 1 Comment »

   
about us | advertise | contact us | home
terms of use | privacy | copyright | site map 		©2012 UBM Canon